534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

oleh: Kaushal Parikh, Aakash Desai, Julian Molina, Aaron Mansfield, Konstantinos Leventakos, Julia Naso, Caleb Smith, Yash Ashara, Beth Pitel, Anastasios Dimou, Ying-Chun Lo

Format: Article
Diterbitkan: BMJ Publishing Group 2023-11-01

Deskripsi

No description available for this item.